Project Grant R21DA062030
Award Date 3/15/26
Completion Date 2/29/28
Dollars Obligated $471K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98101, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Kaiser Foundation Hospitals' Kaiser Permanente Research Institute a $681,667 Project Grant on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop evidence-based interventions addressing e-cigarette and cannabis co-use among young adults in Hawaii. The three-year project (completion date: March 31, 2029) delivers two primary products: (1) an epidemiological analysis phase (R61)...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a $3.24 million Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) to Kaiser Foundation Hospitals, effective June 1, 2025, through February 28, 2030. This research initiative comprehensively characterizes substance use disorder (SUD) care pathways and compares their quality and effectiveness using data from Kaiser Permanente Washington, a large integrated healthcare system. The study leverages...
- Federal Grant Award Summary Kaiser Foundation Hospitals (Kaiser Permanente) received a $1.422 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period of June 15, 2025 through May 31, 2028. The award supports the development and evaluation of a mobile health (mHealth) intervention designed to reduce substance use and HIV risk among young adult women affected by sex trafficking. The project will involve...
- Federal Project Grant Award Summary Kaiser Foundation Hospitals, operating through the Kaiser Foundation Research Institute in Washington, DC, received a $418,224 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded March 1, 2026, with completion targeted for February 29, 2028. The grant funds a mixed-methods research study examining medication adherence trajectories in older patients living with HIV (PLWH) who...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded the University of Southern California a $196,236 Project Grant on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate clinician preconceptions about cannabis use during pregnancy and their impact on prenatal care quality. The award funds a five-year research initiative (through June 30, 2030) led by Dr. Rachel Carmen Ceasar that employs natural language processing and artificial...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $1.49 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Trustees of Columbia University in the City of New York, Health Sciences Division, effective September 15, 2025, with a completion date of May 31, 2030. This grant funds a longitudinal research study examining the impact of cannabis use disorder (CUD) and its treatment on opioid-related health consequences among...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $791,990 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 15, 2025, with an ultimate completion date of April 30, 2030. The award funds a prospective, mechanistic randomized controlled study investigating the bidirectional relationships between cannabis use, sleep, and the hypothalamic-pituitary-adrenal (HPA) axis....
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Medical University of South Carolina a Project Grant totaling $686,692 under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, with completion anticipated by July 31, 2030. This award supports a prospective clinical research trial designed to assess the benefits of cannabis use reduction in adults with Cannabis Use Disorder (CUD). The research addresses a significant evidence...
- Federal Grant Award Summary Michigan State University, in partnership with Henry Ford Health, received a $183,681 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded March 15, 2026. This research initiative will develop and test a patient-engaged technology-based intervention targeting the reduction of prenatal cannabis use. The project will establish an Electronic Screening and Brief Intervention (ESBI) combined...
- Federal Project Grant Award Summary The University of California, San Diego received a $187,777 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025 through August 31, 2030. This award supports longitudinal research examining the interactive effects of caffeine and cannabis use on neurocognitive outcomes in adolescents and young adults. The project will analyze long-term trends in...